Orexigen Therapeutics

Jun 18, 2019

Global Anti-Obesity Drugs Market Outlook to 2024: Online Drug Stores Boost Sales

Mar 12, 2018

Orexigen Therapeutics, Inc. Plans For Near-term Sale Using Structured Process Through Chapter 11 Of U.S. Bankruptcy Code

Nov 13, 2017

Orexigen Therapeutics Announces Third Quarter 2017 Financial Results

Nov 13, 2017

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Merck KGaA, Darmstadt, Germany for Contrave in Latin America

Oct 31, 2017

Orexigen Therapeutics to Provide Business Update and Discuss Third Quarter 2017 Financial Results on November 13, 2017

Aug 29, 2017

Orexigen Therapeutics to Speak at Upcoming Investor Conferences

Aug 07, 2017

Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Cheplapharm Arzneimittel GmbH for Mysimba(TM) in Germany, France and Austria

Jul 26, 2017

Orexigen Therapeutics Announces Expansion of Distributorship Agreement with Biologix FZCO for Contrave® (naltrexone HCl / bupropion HCl extended release) to Egypt

Jul 25, 2017

Orexigen Therapeutics to Provide Business Update and Discuss Second Quarter 2017 Financial Results on August 8, 2017

May 31, 2017

How These Drug Makers Stocks are Faring? -- Depomed, Pernix Therapeutics, United Therapeutics, and Orexigen Therapeutics